Fortrea Holdings Inc의 수익 품질 점수는 B/39.4425입니다. 이 점수는 수익성, 성장, 현금 창출 및 자본 배분, 레버리지의 네 가지 차원을 기반으로 합니다.
Fortrea Holdings Inc는 언제 수익을 보고하나요?
Fortrea Holdings Inc의 다음 수익 보고서는 2026-08-03에 발표될 예정입니다.
Fortrea Holdings Inc의 예상 수익은 얼마인가요?
월스트리트 애널리스트에 따르면 Fortrea Holdings Inc의 예상 수익은 $637.9M입니다.
Fortrea Holdings Inc은 수익 기대치를 충족했나요?
Fortrea Holdings Inc의 최근 수익은 $636.5M로, 기대치를 미달하다.
주요 통계
이전 종가
$16.87
시가
$16.77
일일 범위
$16.39 - $16.94
52주 범위
$4.35 - $18.67
거래량
586.6K
평균 거래량
1.5M
배당수익률
--
EPS(TTM)
-4.91
시가총액
$1.5B
FTRE란 무엇인가요?
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.